While the activated viral Src oncoprotein, v-Src, induces uncontrolled cell growth, the mechanisms underlying cell cycle deregulation by v-Src have not been fully de®ned. Previous studies demonstrated that v-Src induces constitutively active STAT3 signaling that is required for cell transformation and recent data have implicated STAT3 in the transcriptional control of critical cell cycle regulators. Here we show in mouse ®broblasts stably transformed by v-Src that mRNA and protein levels of p21 (WAF1/CIP1), cyclin D1, and cyclin E are elevated. Using reporter constructs in transient-transfection assays, the cyclin D1 and p21 promoters were both found to be transcriptionaly induced by v-Src in a STAT3-dependent manner. The kinase activities of cyclin D/ CDK4, 6 and cyclin E/CDK2 complexes were only slightly elevated, consistent with the ®ndings that coordinate increases in p21, cyclin D1 and cyclin E resulted in an increase in cyclin/CDK/p21 complexes. Similar results were obtained in NIH3T3 and BALB/c 3T3 cells stably transformed by v-Src, indicating that these regulatory events associated with STAT3 signaling represent common mechanisms independent of cell line or clonal variation. These ®ndings suggest that STAT3 has an essential role in the regulation of critical cell cycle components in v-Src transformed mouse ®broblasts.
Introduction
Signal Transducers and Activators of Transcription (STATs) are latent cytoplasmic transcription factors that were initially discovered as mediators of cellular responses to interferons . STATs are activated by tyrosine phosphorylation resulting in dimerization and translocation to the nucleus, where they regulate the transcription of target genes by binding to speci®c DNA-response elements (Schindler and Darnell, 1995; Darnell, 1997; Bromberg and Darnell, 2000) . STAT signaling has been implicated in the control of multiple cellular responses to diverse cytokines and growth factors, including cell proliferation, dierentiation and apoptosis (Zhong et al., 1994; Bromberg et al., 1996; Fukada et al., 1996; Hauser et al., 1998; Catlett-Falcone et al., 1999a) . In addition, constitutive activation of STAT family members has been demonstated in a wide variety of human tumors, consistent with a role for STATs in oncogenesis (Carlesso et al., 1996; Gouilleux-Gruart et al., 1996; Weber-Nordt et al., 1996; Chai et al., 1997; Garcia et al., 1997; Grandis et al., 1998; Catlett-Falcone et al., 1999b; Frank, 1999; Bowman et al., 2000) .
The transforming oncoprotein encoded in Rous sarcoma virus, v-Src, is a non-receptor tyrosine kinase that induces cell transformation through unregulated tyrosine phosphorylation of cellular proteins (Jove and Hanafusa, 1987) . Previous studies have demonstrated that v-Src transformation results in the constitutive activation of one STAT family member, STAT3 (Yu et al., 1995; Cao et al., 1996; Chaturvedi et al., 1997) . Signi®cantly, activation of STAT3 by v-Src results in the induction of speci®c gene expression and has been shown to be required for cell transformation (Bromberg et al., 1998b; Turkson et al., 1998 Turkson et al., , 1999 . Constitutive activation of STAT3 signaling also has a role in cell transformation by numerous other oncoproteins, including v-Abl, v-Eyk, v-Fps, v-Sis and v-Ros (Danial et al., 1995; Garcia et al., 1997; Zong et al., 1998; Besser et al., 1999; Bowman et al., 2000) . Moreover, recent studies have demonstrated that mutationally-activated STAT3 is sucient to transform cells . One critical target gene of STAT3 implicated in oncogenesis is Bclx, which confers resistance to apoptosis (CatlettFalcone et al., 1999b; Bromberg et al., 1999; Karni et al., 1999) . However, it is likely that STAT3 regulates multiple cellular genes that contribute to oncogenesis, including genes involved in cell cycle control.
Cell cycle progression is controlled by the activity of serine/threonine kinases known collectively as cyclindependent kinases (CDKs) (Sherr, 1993) . The activity and speci®city of the CDKs are determined by their association with an active cyclin subunit, and dierent cyclin/CDK complexes are active at speci®c points within the cell cycle. G1 through S phase cell cycle progression is controlled by three cyclin/CDK complexes, D1-3, E, and A. The D cyclins associate with CDK 4 and 6, while cyclins A and E associate with CDK2 (Sherr, 1993) . A critical eector of these active complexes is the retinoblastoma protein (Rb) (Dyson, 1998; Nevins, 1998) . The activities of the cyclin/CDK complexes are regulated by two classes of cyclindependent kinase inhibitors (CKI), KIP-CIP and INK4. The INK4 family is comprised of p15, p16, p18 and p19 (Carnero and Hannon, 1998) , while the KIP-CIP family includes p21 WAF1/CIP1 , p27 KIP1 , and p57 (Sherr and Roberts, 1995) . The KIP-CIP inhibitors act by binding to active CDKs, and overexpression of these CKI's has been found to induce G1 arrest (Polyak et al., 1994; Toyoshima and Hunter, 1994; Harper et al., 1995) .
There is evidence that v-Src transformation results in altered expression of cyclins and CKIs, suggesting that Src may induce oncogenesis at least in part by modulating the expression of critical components of cell cycle regulation (Johnson et al., 1998a; Lee et al., 1999) . Furthermore, other studies indicate that STATs regulate expression of the p21 WAF1/CIP1 and cyclin D genes (Chin et al., 1996; Matsumura et al., 1997; Bellido et al., 1998; Johnson et al., 1998b; Florenes et al., 1999; Wen et al., 1999) . Since earlier studies have shown that cell transformation by v-Src is dependent on activated STAT3 signaling (Turkson et al., 1998; Bromberg et al., 1998b; Bowman et al., 2000) , these ®ndings suggest that STAT3 may play a role in controlling expression of cell cycle regulators in cells transformed with v-Src. Here we report that mouse ®broblasts stably transformed by vSrc exhibit upregulation of cyclin D1, cyclin E and p21 WAF1/CIP1 expression, concomitant with constitutive activation of STAT3. Furthermore, this regulation of cyclin D1 and p21 WAF1/CIP1 occurs at the transcriptional level and is dependent on STAT3. These results demonstrate that v-Src induces alterations in expression of key cell cycle regulators through mechanisms involving constitutive activation of STAT3 signaling.
Results

Transformation by v-Src induces p21
WAF1/CIP1 expression Three STAT binding sites were previously identi®ed in the promoter region of the p21 WAF1/CIP1 gene (el-Deiry et al., 1993; Chin et al., 1996) ; two of the sites were shown to bind STAT1 and one was found to bind both STAT1 and STAT3 (Chin et al., 1996) . Furthermore, it has also been demonstrated that activation of STAT1 by various means induces the p21 WAF1/CIP1 promoter (Chin et al., 1996; Johnson et al., 1998b) . Activation of STAT1 has been primarily associated with growth inhibition (Bromberg et al., 1996 (Bromberg et al., , 1998a , and the observation that p21 WAF1/CIP1 levels are increased in cells with activated STAT1 ®ts the classical model that p21 is growth inhibitory . By contrast, STAT3 activation is frequently associated with proliferation (Yu et al., 1995; Turkson et al., 1998; Bromberg et al., 1999) . Based on these ®ndings, it was not clear whether activation of STAT3 by v-Src would induce p21 WAF1/CIP1 expression, particulary in the context of oncogenesis. NIH3T3 and BALB/c 3T3 ®broblasts stably transformed by v-Src represent two independent cell lines containing constitutively active STAT3, but not STAT1, compared to their normal non-transformed counterparts (Yu et al., 1995; Garcia et al., 1997) . The Western blot in Figure 1a shows that steady-state levels of p21 WAF1/CIP1 protein are higher in the v-Src transformed cells compared to normal ®broblasts. As a control for protein normalization, we probed the blot with antibodies to Raf-1, which is not altered by v-Src transformation (our unpublished results). The elevated p21 levels are surprising given that v-Src expressing cells have a transformed phenotype and are actively proliferating.
To determine if the increase in p21 WAF1/CIP1 protein in the v-Src transformed cell lines is due to an increase in p21 WAF1/CIP1 message, total RNA was isolated from both cell lines and steady-state levels of p21 WAF1/CIP1 transcript were measured by Northern blot analysis. WAF1/CIP1 protein and mRNA levels were determined in exponentially growing NIH3T3 and Balb/c 3T3 cells. (a) Western blot analysis was performed on whole-cell lysates prepared using boiling SDS sample buer. Equal amounts of protein were loaded in each lane and, following transfer to nitrocellulose, the blots were probed with the indicated antibodies. Equalization of total protein is con®rmed by amount of Raf-1 protein, which is not altered by v-Src transformation. (b) Total mRNA was puri®ed by the guanidine isothiocyanate method and resolved on a 1% agarose-formaldyhyde gel, transferred to a nylon membrane, and probed with a 32 P-labeled cDNA probe. Equalization and integrity of RNA was veri®ed by levels of 28S and 18S ribosomal RNA Induction of cyclin D1 and p21 by Src D Sinibaldi et al
Compared to the normal cell lines, the levels of p21 WAF1/CIP1 mRNA were increased 2 ± 3-fold in NIH3T3 and BALB/c 3T3 ®broblasts transformed with v-Src (Figure 1b) . To assess if STAT3 was contributing to the induction of p21 WAF1/CIP1 mRNA, a portion of the human p21 WAF1/CIP1 promoter linked to a luciferase reporter was used in transient transfection assays of NIH3T3 cells (el-Deiry et al., 1993) . A 2.4 kb fragment of the promoter was shown to contain one of the three STAT-binding sites, which binds both STAT1 and STAT3 in electrophoretic mobilty shift assays (Chin et al., 1996) . Activation of endogenous STAT3 by transfection with v-Src resulted in a 5 ± 6-fold induction of this p21
promoter fragment (Figure 2a ). This induction was signi®cantly reduced by a dominant-negative form of STAT3, designated STAT3b (Caldenhoven et al., 1996; Turkson et al., 1998) . However, the p21 promoter was not completely repressed by the dominant-negative STAT3b, suggesting that additional factors contribute to the induction of this promoter. Consistent with this possibility, deletion of the sole p53 binding site resulted in only a 3 ± 4-fold induction of the p21 WAF1/CIP1 promoter, which was nearly completely repressed by dominantnegative STAT3b (Figure 2b ). These results indicate that Src-mediated induction of the p21 promoter by STAT3 was both p53-dependent and p53-independent.
Expression of cyclin D1 and E is induced by v-Src
To assess the potential signi®cance of the p21
results, it was important to determine if the expression or activity of other key cell cycle regulatory proteins were also altered by v-Src transformation. Figure 3 shows a Western blot analysis of the levels of major cyclins, CDKs, and CKIs responsible for G1 to S phase progression. Three proteins in the panel show consistent alterations in NIH3T3 and BALB/c 3T3 cells associated with v-Src transformation. The levels of cyclin D1 and cyclin E are both signi®cantly increased in v-Src transformed cells, whereas the levels of cyclin A are slightly decreased. There is no consistent expression pattern among the cell lines for any of the other proteins examined. For example, cyclin D2 is higher in normal NIH3T3 but not BALB/c 3T3 cells, and CDK6 is higher in normal NIH3T3 cells but nearly equal in BALB/c 3T3 cells compared to their transformed counterparts. These variations are most likely due to cell line or clonal variations and thus are probably not central to transformation of mouse ®broblasts by v-Src.
To determine if these changes in cyclin protein expression correspond to changes in CDK activity, kinase assays were performed for cyclin A, E and D1. These cyclins were immunoprecipitated with the corresponding antibodies and incubated in in vitro kinase assays with puri®ed histone H1 or GST-Rb proteins as substrates ( Figure 4 ). There was a decrease in the kinase activity of cyclin A/CDK2 in response to v-Src transformation, consistent with the decrease in cyclin A protein levels. By contrast, cyclin D1/CDK4, 6 and cyclin E/CDK2 activities were slightly higher in v-Src transformed cells as compared to their normal counterparts. Similar results were obtained when CDK2 or CDK4 were immunoprecipitated directly and assayed for kinase activity in vitro (data not shown). In particular, the total kinase activity for CDK2 did not show any signi®cant variation between normal and v-Src transformed ®broblasts, suggesting that coordinate increase of cyclin E activity and decrease of cyclin A activity results in no overall change in CDK2 activity. Moreover, the CDK4 kinase activity showed a pattern identical to the cyclin D1-associated kinase activity. Thus, the kinase activities associated with cyclins D1 and E were not inhibited despite the elevated levels of p21 WAF1/CIP1 expression in v-Src transformed cells.
Transcriptional regulation of cyclin D1 expression
To assess the role of STAT3 in regulation of other cell cycle components, we determined if the cyclin D1 gene was transcriptionally regulated by v-Src transformation in the same manner as p21 WAF1/CIP1 . The Northern blot analysis in Figure 5 shows that steady-state levels of cyclin D1 mRNA are consistently higher in v-Src transformed cells as compared to normal ®broblasts. Our analysis of the murine D1 promoter revealed (Seidel et al., 1995) . To determine if v-Src could regulate the D1 promoter in a STAT3-dependent manner, a 984 bp fragment of the mouse D1 promoter linked to a luciferase reporter was used (G Peters, unpublished data). NIH3T3 cells transiently transfected with the cyclin D1 promoter and v-Src displayed a 4 ± 5-fold induction of the D1 promoter ( Figure 6 ). This induction was abolished by co-transfection of the dominant-negative variant, STAT3b, indicating that STAT3 contributes to transcriptional regulation of cyclin D1 in response to v-Src.
Association of p21
WAF1/CIP1 with cyclin E and D1 complexes
To better understand how elevated p21 expression in¯uences cyclin/CDK complexes, we performed immunoprecipitations of p21 WAF1/CIP1 and determined the levels of co-precipitated cyclin D1 and E. As shown in Figure 7 , the amount of cyclin D1 bound to p21 WAF1/CIP1 is substantially greater in v-Src transformed cells compared to normal ®broblasts. To a lesser extent, this increase is also noted for cyclin E. These results Figure 3 Expression of major G1 cell cycle regulatory components in v-Src transformed cells. Western blot analysis was performed on whole-cell lysates prepared using boiling SDS sample buer. Equal amounts of protein were loaded in each lane and, following transfer to nitrocellulose, the blots were probed with the indicated antibodies. Equalization of protein loading is con®rmed by Raf-1 levels Figure 4 Kinase activities of critical G1 cyclin/CDK complexes regulated by v-Src. Immunoprecipitations were performed for the G1 cyclins A, E, and D1 and the kinase activities of these complexes were determined in vitro by phosphorylation of histone H1 or GST-Rb as substrate. The 32 P-phosphorylated substrates were then resolved by 12% polyacrylamide-SDS gel electrophoresis and analysed by PhosphorImager (Molecular Dynamics). Experiments were repeated at least three times with similar results Figure 5 Cyclin D1 mRNA is increased in v-Src transformed ®broblasts. Northern blot analysis of RNA from exponentially growing NIH3T3 and Balb/c 3T3 cells. Total RNA was puri®ed by the guanidine isothiocyanate method and resolved on a 1% agarose-formaldehyde gel, transferred to a nylon membrane, and probed with a complexes. The supernatant remaining after the p21 WAF1/CIP1 immunprecipitation was then examined for p21-free cyclin/CDK complexes by immunoprecipitating CDK2 and CDK4 followed by Western blot analysis for cyclin E and cyclin D1, respectively. The level of cyclin E/CDK2 remained relatively constant in the normal and v-Src transformed cell lines. By contrast, the amount of cyclin D1/CDK4 was increased in ®broblasts stably transformed with vSrc compared to their normal counterparts. The levels of p21-free cyclin D1/CDK4 and cyclin E/CDK2 correspond well with the kinase activities of both complexes (compare Figures 4 and 7) . Taken together, these ®ndings suggest that coordinate increases in cyclins D1 and E expression compensate for increased p21 WAF1/CIP1 expression in v-Src transformed cells, thereby allowing cell cycle progression.
Discussion
STAT3 has been shown to be constitutively activated in cell lines transformed by diverse oncoproteins as well as in many human cancers Catlett-Falcone et al., 1999a; Bowman et al., 2000) . Previous studies have established that STAT3 signaling is essential for the transformation of NIH3T3 cells by v-Src, and that STAT3 activation by v-Src results in speci®c gene induction (Bromberg et al., 1998b; Turkson et al., 1998 Turkson et al., , 1999 ). Here we demonstrate that STAT3 activation by v-Src is able to alter the expression of major regulators of cell cycle progression at the transcriptional level. Based on these ®ndings, we propose a model for the role of STAT3 activation in control of critical cell cycle regulators during transformation of mouse ®broblasts by v-Src (Figure 8 ). We have shown that v-Src induces both p21 and cyclin D1 expression in a STAT3-dependent manner at the transcriptional level. The increased cyclin D1 protein can form active complexes with CDK 4 and 6. These active complexes can phosphorylate Rb, releasing active E2F, which has been shown to induce both cyclin E and p21 at the transcriptional level (Ohtani et al., 1995; Botz et al., 1996; Geng et al., 1996; Lee et al., 1998) . The coordinate upregulation of p21 and cyclins D1 and E evidently provides v-Src transformed mouse ®broblasts with enough active cyclin/CDK complexes to proceed through the cell cycle.
STAT1 activation by IFN-g has been shown to result in the induction of p21 WAF1/CIP1 and growth arrest WAF1/CIP1 antibody to detect p21-associated cyclins D1 and E (left panel). The supernatant remaining from the initial IP was then immunoprecipitated with antibodies to CDK2 or 4 to detect p21-free cyclins E or D1, respectively (right panel). Conjugates were washed 36 with IP buer and proteins were resolved on a 12% polyacrylamide-SDS gel, transferred to nitrocellulose, and probed with the indicated antibodies. Immunoprecipitation experiments were performed three times with similar results. All of the p21 was immunoprecipitated in the ®rst IP, as no more p21 could be detected in the supernatant Figure 8 Proposed model for coordinate upregulation of cyclin D1 and p21 by v-Src. Transformation of mouse ®broblasts by vSrc results in constitutive activation of STAT3, which activates the promoters of p21 WAF1/CIP1 and cyclin D1. This coordinate increase in expression of both proteins results in slightly higher cyclin D1/CDK activity, followed by increased phosphorylation of Rb and release of E2F. Activated E2F in turn induces the cyclin E and p21 WAF1/CIP1 promoters, further increasing the p21 expression levels. The increased p21 levels may be required for assembly of active cyclin/CDK complexes, while the coordinate increases in cyclin D1 and E may compensate for the elevated levels of p21, thereby allowing sucient cyclin/CDK activity for cell cycle progression. See text for further details Oncogene Induction of cyclin D1 and p21 by Src D Sinibaldi et al (Bromberg et al., 1996 (Bromberg et al., , 1998a Chin et al., 1996) . Based on data suggesting that STAT1 is often associated with growth arrest and that STAT3 activation is associated with proliferation (Akira, 1999; Catlett-Falcone et al., 1999a; Bromberg and Darnell, 2000) , we predicted that STAT3 activation by v-Src may repress p21 WAF1/CIP1 transcription, thus contributing to cell cycle deregulation. Instead, we found that v-Src transformation of both NIH3T3 and BALB/c 3T3 cells surprisingly resulted in elevated levels of p21 WAF1/CIP1 , in contrast to the classical model of p21 WAF1/CIP1 being growth inhibitory. Similar to our ®ndings, other studies have shown that various human cancers possess elevated levels of p21 WAF1/CIP1 , indicating that upregulation of p21 WAF1/CIP1 does not always result in growth inhibition (Erber et al., 1997; Barboule et al., 1998; Qin et al., 1998; Shimizu et al., 1999) . Also consistent with our ®ndings, recent studies have shown that interleukin-6 (IL-6) can induce p21 WAF1/CIP1 at the transcriptional level in osteoblastic cells, and that this induction is mediated by STAT3 (Bellido et al., 1998) . However, in contrast to our results, the increases in p21 WAF1/CIP1 resulted in growth arrest of these osteoblastic cells (Bellido et al., 1998) . The ability of v-Src transformed cells to proliferate in response to elevated levels of p21 WAF1/CIP1 led us to examine other cell cycle components, including cyclins D1 and E.
Our ®ndings demonstrate that v-Src induces expression of the cyclin D1 promoter, consistent with the recent ®ndings of others (Lee et al., 1999) . While the evidence suggests that STAT3 directly regulates the p21 promoter (Chin et al., 1996; Bellido et al., 1998) , it remains to be determined whether STAT3 acts directly by binding to the cyclin D1 promoter or through an intermediate. Our analysis of the mouse D1 promoter revealed that it contains at least six potential STAT3 binding sites (D Sinibaldi and R Jove, unpublished data), allowing the possibility that STAT3 may act directly through the promoter. Despite substantially elevated levels of cyclin D1 and E, however, the kinase activities for D1 and E associated CDKs are only slightly higher in v-Src transformed cells compared to normal cells. This is consistent with our ®nding that the coordinate increases in p21 WAF1/CIP1 and cyclins D1 and E resulted in a greater number of cyclin/CDK/p21 WAF1/CIP1 complexes. The slightly higher activity level for cyclin D1/ CDK4 re¯ects an increase in p21-free cyclin D1/ CDK4 complexes in v-Src transformed cells compared to that in normal cells. Furthermore, the reduction in cyclin A/CDK2 activity suggests that lack of increased cyclin A expression resulted in a greater number of cyclin A/CDK2/p21 WAF1/CIP1 complexes and thus reduced kinase activity. Based on the fact that v-Src transformed NIH3T3 and BALB/c 3T3 cells progress though the cell cycle, the reduced activity of cyclin A/ CDK2 is not sucient to block entry into S phase. Recently, genetic evidence for the oncogenic potential of STAT3 was presented using a constitutivelyactivated mutant of STAT3 . In these studies, mutationally-activated STAT3 alone was sucient for transformation, and rat 3Y1 ®broblasts expressing activated STAT3 showed a 3 ± 5-fold increase in the levels of cyclin D1, consistent with STAT3 playing a critical role in cyclin D1 transcriptional regulation.
Although the physiological signi®cance of coordinate upregulation of cyclin D1 and p21 WAF1/CIP1 by v-Src remains to be determined, there are several plausible models for how these processes may contribute to altered growth control in oncogenesis. First, it has been proposed that p21 WAF1/CIP1 not only acts as a inhibitor of CDK activity, but also functions as a scaolding protein for the assembly of active cyclin/CDK complexes (LaBaer et al., 1997) . Moreover, a recent study suggests that p21 WAF1/CIP1 is necessary for cyclin D/CDK activity in murine ®broblasts (Cheng et al., 1999) . Thus, p21 WAF1/CIP1 upregulation may be initiated by an increase of D1 protein, thereby allowing greater numbers of active complexes to be formed. Consistent with this possibility, earlier studies have shown that ectopic overexpression of cyclin D1 resulted in increased levels of p21 WAF1/CIP1 in rodent ®broblasts and human gliomas (Hiyama et al., 1997) . Second, other studies have indicated that overexpression of cyclin D1 and E causes a shortening of G1 phase (Liu et al., 1995; Johnson et al., 1998a) . Thus, the increased p21 WAF1/CIP1 levels may be part of a regulatory mechanism for restricting the CDK-associated kinase activities within a limited range, which in turn may ensure viability of the cells by preventing premature initiation of DNA synthesis. Third, it has been shown in normal quiescent ®broblasts that induction of cyclin D1 by PDGF sequesters the CDK inhibitor, p27 KIP1 , in cyclin D1/CDK complexes, thereby allowing activation of cyclin E-and cyclin A-associated kinases and entry into S phase (Winston et al., 1996) . Similarly, the increase in cyclin D1 induced by v-Src transformation may titrate the pool of available p21 WAF1/CIP1 and thus result in activation of sucient amounts of cyclin Eand cyclin A-associated kinases to allow cell cycle progression. While further studies will be required to distinguish among these and other possible models, our ®ndings indicate that STAT3 contributes to altered expression of critical cell cycle regulators induced by vSrc.
Coordinate upregulation of p21
, D1, and E is not limited to v-Src transformed mouse ®broblasts. Recent studies have identi®ed numerous human tumors that have elevated levels of cyclin D1, p21 WAF1/CIP1 , and cyclin E (Barboule et al., 1998; Hibberts et al., 1999; Kenny et al., 1999; Lonardo et al., 1999) . There are several lines of evidence, including the requirement for activated STAT3 in v-Src transformation (Turkson et al., 1998; Bromberg et al., 1998b) , the ®nding that mutationally-activated STAT3 can act as an oncogene , and the elevated levels of activated STAT3 found in many human tumors Catlett-Falcone et al., 1999a; Bowman et al., 2000) , indicating that STAT3 has an important role in tumorigenesis. Thus, constitutive STAT3 activation may contribute to the coordinate increases in expression of p21 and cyclins D1 and E observed in human tumors. The ®nding that cyclin D1 is required for transformation by the v-H-Ras and cerbB-2/Neu oncoproteins illustrates its importance among cell cycle regulators (Liu et al., 1995; Lee et al., 2000) . Consistent with our results reported here, STAT5 has recently been shown to regulate the cyclin D1 promoter (Matsumura et al., 1999; Wen et al., 1999) . In this context, it may be highly relevant that STAT3 and STAT5 are the STAT family members Induction of cyclin D1 and p21 by Src D Sinibaldi et al most frequently associated with oncogenesis (CatlettFalcone et al., 1999a; Frank, 1999; Bowman et al., 2000) . In addition to altering the expression of critical cell cycle regulators, STAT3 most likely controls multiple genes, including the apoptosis regulator Bcl-x (Catlett-Falcone et al., 1999b; Bromberg et al., 1999; Karni et al., 1999) , which act in concert to confer the fully transformed phenotype.
Materials and methods
Western blot analysis
Whole-cell lysates were prepared in boiling sodium dodecyl sulfate (SDS) sample buer in order to extract total proteins from cytoplasm and nucleus. Equivalent amounts of total cellular protein were electophoresed on 12 ± 15% polyacrylamide-SDS gels and transferred to nitrocellulose membranes. Probing of nitrocellulose membranes with primary antibodies and detection of horseradish peroxidase-conjugated secondary antibodies by enhanced chemiluminesence (Amersham) were performed as previously described (Garcia et al., 1997) . Antibody probes used were rabbit polyclonal antibodies against cyclin A (kind gift of E Leof, Mayo Clinic, Rochester, MN, USA), mouse monoclonal antibodies against p21 WAF1/CIP1 (UBI), cyclin E, D1, CDK2, 4, 6, RAF-1 (Santa Cruz Biotechnologies) and p27 KIP1 (WJ Pledger, unpublished results).
Cell culture and transfections
NIH3T3 and BALB/c 3T3 ®broblasts were grown in Dulbecco's modi®ed Eagle's medium (DMEM) containing 5 or 10% iron-supplemented bovine calf serum, respectively. Transfections were carried out by the standard calcium phosphate method (Turkson et al., 1998) . NIH3T3 ®broblasts were seeded at 5610 5 cells/10 cm plate in DMEM plus 5% BCS at 18 ± 24 h prior to transfection. Total DNA for transfection was typically 20 mg per plate, including 1 mg of luciferase reporter construct (p21 WAF1/CIP1 or cyclin D1 promoter), 0.2 mg of b-galactosidase (b-Gal) internal control vector, and 4 mg of v-Src expression vector. Transfection was terminated 15 h later by aspirating the medium, washing the cells with 16 phosphate-buered saline (PBS), and adding fresh DMEM. The p21 WAF1/CIP1 and cyclin D1 promoter constructs were the generous gifts of B Vogelstein (Johns Hopkins University, Baltimore, MD, USA) and G Peters (Imperial Cancer Research Fund Laboratories, London, UK, respectively.
Preparation of cytosolic extracts
For transient expression assays, cytosolic extracts were prepared from cells at 48 h post-transfection. Cells were washed 26 with 16 PBS and equilibrated for 5 min with PBS-0.5 mM EDTA. Cells were then scraped o of the dishes and the cell pellet was obtained by centrifugation (4500 g, 5 min, 48C). Cells were resuspended in 0.4 ml of low salt HEPES buer (10 mM HEPES [pH 7.8], 10 mM KCl, 0.1 mM EGTA, 0.1 mM EDTA, 1 mM phenylmethylsulfonyl¯uoride, and 1 mM dithiothreitol) for 15 min, lysed by the addition of 20 ml of 10% Nonidet P-40, and centrifuged (10 000 g, 30 s, 48C) to obtain the cytosolic supernatant. Luciferase activity was detected with a luminometer and b-Gal expression was detected by absorbance at A 570 as previously described (Turkson et al., 1998) . As an internal control for transfection eciency, results were normalized to b-Gal activity. Luciferase assays were performed in triplicate and repeated at least three times in independent transfection experiments.
Northern blot analysis
Total RNAs were isolated by the guanidine isothiocyanate method as previously described (Chomczynski and Sacchi, 1987) . Fifteen mg of total RNA was separated on 1% agarose-formaldehyde gels and electroblotted onto Hybond-N + nylon membranes (Amersham). Small aliquots of the same RNA samples were separated on parallel nondenaturing 1% agarose gels and stained with ethidium bromide to con®rm normalization and integrity of RNAs. Blotted membranes were hybridized at 658C in 1 mM EDTA-0.5 M Na 2 HPO 4 (pH 7.2), 7% SDS for 18 ± 24 h with 1 ± 2610 6 c.p.m. of the DNA probe per ml. DNA probes were labeled with 32 P-dCTP by random primer labeling (Boehringer Manheim) to a speci®c activity of 1 ± 3610 8 c.p.m./mg. After hybridization, membranes were washed twice for 1 h in 1 mM EDTA-40 mM Na 2 HPO 4 (pH 7.2), 5% SDS at 658C. Each Northern blot analysis was repeated several times to con®rm reproducibility.
Probes for hybridization of Northern blots were obtained by restriction endonuclease digestion of plasmids containing cDNAs for individual genes. Transcripts of p21 WAF1/CIP1 were detected by a 440-bp BamHI/EcoRI fragment of the p21 WAF1/CIP1 cDNA corresponding to exon 2. Transcripts of cyclin D1 were detected by a 1110-bp BamHI/EcoRI fragment corresponding to the 5' end of cyclin D1 mRNA.
Immunoprecipitations
Whole-cell lysates were obtained by washing cells 26 with 16 PBS and 300 ± 500 ml of IP Buer (50 mM HEPES [pH 7.4], 250 mM NaCl, 2 mM EDTA, 2 mM NaFl, 0.1 mM Na 2 VO 3 , 1 mM DTT, 0.5 mM PMSF, 10 mg/ml leupeptin, 0.1% Tween 20) was added to each 10 cm plate. The cells were then harvested on ice and allowed to lyse for 20 min with vortexing every 5 min. Protein concentrations were determined by Bradford assay (Bio-Rad) and equal amounts of protein (400 mg) were immunoprecipitated with antip21 WAF1/CIP1 agarose-conjugated antibody (Santa Cruz Biotechnologies). In some experiments where indicated in the text, proteins were immunoprecipitated from supernatants with anti-CDK2 or anti-CDK4 antibodies (Sant Cruz Biotechnologies) and pelleted following incubation with protein-A agarose.
Histone and Rb kinase assays
Proteins from 100 mg of total lysate were immunoprecipitated overnight with antibodies to cyclin A, E, or D1 (Santa Cruz Biotechnologies). Thirty ml of a 50% protein A-agarose slurry was added to each sample and allowed to rock at 48C for 1 h. The protein A-agarose was then pelleted by centrifugation (13 000 g) for 1 min. The supernatant was then removed and the pellet was washed 26 with IP buer and 16 with kinase buer (50 mM Tris-Cl [pH 7.4], 10 mM MgCl 2 , 5 mM MnCl 2 , 1 mM DTT). The pellets were then resuspended in 30 ml reaction buer (1 mg GST-Rb or histone H1, 20 mM cold ATP, 10 mCi [g-32 P]ATP) and incubated at 308C for 30 min. The reaction was stopped by the addition of 26SDS sample loading buer and resolved by 12% polyacrylamide-SDS gel electrophoresis. The gel was ®xed for 30 min in 10% acetic acid, 10% methanol and analysed using a PhosphorImager (Molecular Dynamics).
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